[Short course antibiotherapies in community-acquired pneumonia].
The use of antibiotics for longer duration contributes to some disadvantageous conditions such as the development of resistant bacteria, increased bacterial colonization and an increase in the costs. In addition, in terms of suggested therapy durations, there are some differences between guidelines for the diagnosis and treatment of pneumonia. In some studies, especially in the studies performed using new flouroquinolon and macrolide antibiotics in recent years, it has been shown that short course antimicrobial therapies for pneumonia are as effective as the traditional long therapies and are advantageous for lowering bacterial colonization and costs. In this article, short course therapy in community-acquired pneumonia is reviewed under the light of current literature.
Bulbul
Yilmaz
Y
Department of Chest Diseases, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey. bulbulyilmaz@yahoo.com
Ozlu
Tevfik
T
D000900:Anti-Bacterial Agents / Q000191:economics* / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000188:drug therapy*; D003362:Cost-Benefit Analysis; D004305:Dose-Response Relationship, Drug; D024881:Drug Resistance, Bacterial; D006801:Humans; D011014:Pneumonia / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents